Silver Book Fact

Fact image

Percentage Change in Age-Adjusted Death Rates From Cardiovascular Disease (CVD) And Other Causes Since 1950, United States, 1950-2002

Weisfeldt M, Zeiman S. Advances in the Prevention and Treatment of Cardiovascular Disease: One of the most important contributors to improved human survival is the treatment of cardiovascular disease. Health Aff. 2007; 26(1): 25-37. http://content.healthaffairs.org/cgi/content/full/26/1/25

Reference

Title
Advances in the Prevention and Treatment of Cardiovascular Disease: One of the most important contributors to improved human survival is the treatment of cardiovascular disease
Publication
Health Aff
Publication Date
2007
Authors
Weisfeldt M, Zeiman S
Volume & Issue
Volume 26, Issue 1
Pages
25-37
URL
Read Full Resource

Categories

  • Cost of Disease
  • Human Burden

Related Facts

  • AFib prevalence projected to double by 2050
    By 2050, the prevalence of atrial fibrillation will have more than doubled since 2001—growing to an estimated 5.6 million to 12.1 million Americans.  
  • Annual incidence of all thromboembolism
    Annual incidence of all thromboembolism, deep vein thrombosis (DVT) alone, and plumonary embolism  (PE) with or without deep vein thrombosis (PE ± DVT) among residents of Olmsted County, Minnesota, from…  
  • When considered separately from cardiovascular disease, stroke is the 3rd leading cause of death in the U.S.  
  • Heart failure incidence approaches 10 per 1,000 of the U.S. population after 65 years of age.  
  • Average age at death from stroke, 2002
    In 2002, the mean age at death from stroke was 79.6 years.